Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 June 2015 09:32
Scientists have hailed the potential of the new drug
A new drug could help patients with a devastating form of lung cancer to live longer, it has been suggested.
Nivolumab, an immuno-therapy drug that unshackles the immune system so it can attack cancerous cells, has been shown to double the life expectancy of genetically targeted patients with advanced non-squamous non-small cell lung cancer.
One expert has described the results of the major international trial as a "paradigm shift" in the battle against lung cancer.
Lung cancer is one of the UK's most serious forms of the disease.
Advanced non-squamous non-small cell lung cancer accounts for around 85% of all cases of the lung disease, which is diagnosed in 43,463 new patients and is responsible for 35,371 deaths each year in the UK.
Overseas travel
Like other cancers, treatment depends on how far it has spread and how good your general health is.
But whether you are a cancer survivor or are undergoing treatment, cancer travel insurance means you can still enjoy jetting off to sunnier climes around the world with family and friends.
Policies can include cover for replacing lost medication and access to 24/7 emergency assistance.
Longer life expectancy
The new research, led by Dr Luis Paz-Ares, from the Hospital Universitario Virgen Del Rocio in Spain, compared the effectiveness of nivolumab and the standard chemotherapy drug docetaxel in 582 patients with advanced non-squamous non-small cell lung cancer.
Nivolumab reduced the risk of dying by 27% compared with docetaxel and increased typical survival time from 9.4 to 12.2 months.
In patients whose cancers produced higher levels of a tumour protein called PD-L1, survival time more than doubled from eight to 19.4 months.
Dr David Chao, consultant medical oncologist at the Royal Free Hospital in London, described the findings as a paradigm shift in the treatment of lung cancer.
20 September 2017
Thousands of Ryanair flights have been cancelled over the next six weeks, as the airline says it "messed up" allocation of its pilots' annual leave.
[more...]
19 September 2017
Manchester's Girlguides are being urged to help the elderly with a new badge incentivising youngsters to tackle senior loneliness.
16 September 2017
Holidaymakers are being evacuated as winds up to 200km per hour hit Central Vietnam, with Typhoon Doksuri damaging houses, roads and infrastructure.
15 September 2017
People in parts of East Anglia are eight times more likely to survive liver disease than Blackpool residents, according to new data by Public Health England (PHE).
14 September 2017
A non-invasive alternative to gastric bypass surgery that helps people with Type 2 diabetes lose weight is being recommended for widespread use by NHS experts.
13 September 2017
Almost half of UK adults travelling to areas at risk of malaria are not covering themselves by taking medication, despite recommendations made by the NHS and world health organisations.
12 September 2017
A new health warning has been issued by scientists in Sweden, suggesting e-cigarettes with nicotine could lead to an increased risk of heart attacks and strokes.
09 September 2017
Researchers have developed a futuristic pen-like device that can tell whether someone has cancer much faster than current technology.
08 September 2017
A staffing crisis in the NHS is seeing cancer patients turned away from their GP surgery and instead visiting A&E, a report has claimed.
07 September 2017
Whether it's binge-watching box-sets, shopping for clothes, chatting to friends or picking up work emails, staying connected is pretty much essential to everyday life.
06 September 2017
Around 1 in 2 GPs do not know that black men have a higher risk of developing prostate cancer, research has suggested.
05 September 2017
Many middle-aged men have hearts in a condition that makes the organ seem older than the men's actual age, a new study has revealed.